Search

everythinglearnresearchcommunity

for

Search:↓

3α-AdiolG is a good marker for androgen activity in women with excessive hair growth and decreases with anti-androgen treatment.

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.

Most patients improved with oral contraceptives, but some needed additional treatment.

Cyproterone Acetate effectively treats androgen-related conditions and is used in prostate cancer therapy and hormone therapy for transgender women.

Cyproterone acetate is a safe treatment that causes mild feminizing effects in adolescent trans-girls.

The treatment showed promising hair regrowth in advanced-stage hair loss.

Spironolactone improved symptoms in women with hormonal imbalances and had few side effects.

Using a protocol with LH improves pregnancy rates in patients with low ovarian reserve.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

AR-27 E-Chol siRNA can effectively regrow hair by reducing androgen receptor gene activity.

The hCG diet and testosterone therapy can cause hair loss in some people.

The treatment showed promising results in improving advanced-stage hair loss.

The treatment temporarily improved symptoms of hyperandrogenism in adolescents.

Ovarian hyperthecosis should be considered in young women with severe male-like symptoms and can be managed with hormone treatments.

A new compound that could treat various androgen-related conditions was created and analyzed.

A new gel helps grow mature eggs in a lab that can be fertilized and develop further.

Cyproterone acetate is effective for treating hirsutism and acne in women by blocking androgens in the skin and also works as a contraceptive.

Goserelin and oestradiol treatment slightly improved hairiness but did not significantly change sebum production or hair characteristics in mildly hirsute women.

Male cells need DHT to respond to testosterone, while female cells do not.

Parental support and gender-affirming care are crucial for the mental health of transgender adolescents.

Removing both ovaries treated the woman's excess male hormone symptoms.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.